FGF/FGFR signaling in hepatocellular carcinoma: From molecular mechanisms to biomarker-guided therapy.
Hepatocellular carcinoma (HCC) is the predominant histological subtype of primary liver cancer and remains a leading cause of cancer-related mortality because of its molecular heterogeneity, high recurrence rate, and incomplete responses to systemic therapy. Among dysregulated oncogenic networks, fibroblast growth fact...